Skip to main content
. 2021 Feb 18;35:106859. doi: 10.1016/j.dib.2021.106859

Fig. 1.

Fig 1

Median CCL18 serum level shown along the different histological subgroups. The median CCL18 was higher in the group of patients with malignancy compared to the control group (patients with benign disease) (Median CCL 18 Level was 47 ng/ml (C) vs 95 ng/ml (AC) vs. 179 ng/ml (SQC); p<0.0001) (C = Control group with benign disease, AC= adenocarcinoma, SQC= squamous carcinoma).